Popliteal Artery Aneurysm Repair in the Endovascular Era. Issue 30 (July 2015)
- Record Type:
- Journal Article
- Title:
- Popliteal Artery Aneurysm Repair in the Endovascular Era. Issue 30 (July 2015)
- Main Title:
- Popliteal Artery Aneurysm Repair in the Endovascular Era
- Authors:
- Ronchey, Sonia
Pecoraro, Felice
Alberti, Vittorio
Serrao, Eugenia
Orrico, Matteo
Lachat, Mario
Mangialardi, Nicola
Dai, Yamanouchi. - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Abstract</title> <p>To compare outcomes of popliteal artery aneurysm (PAA) repair by endovascular treatment, great saphenous vein (GSV) bypass, and prosthetic bypass.</p> <p>Single center retrospective analysis of patients presenting PAA from 2000 to 2013. Patients were divided into endovascular treatment (group A); GSV bypass (group B); and prosthetic graft bypass (group C). Outcomes were technical success, perioperative mortality, and morbidity. Survival, primary and secondary patency, and freedom from reintervention rate were estimated. Differences in ankle-brachial index (ABI), in-hospital length of stay (InH-Los), red blood cell (RBC) transfusion, and limb loss were reported. Mean follow-up was 49 (median: 35; 1–145; SD 42) months.</p> <p>Sixty-seven patients were included; 25 in group A, 28 in group B, and 14 in group C. PAA was symptomatic in 23 (34%) cases. Technical success was 100%. No perioperative death occurred. Three (4.5%) perioperative complications were reported with no significant difference between groups (<italic>P</italic> = 0.866). Five-years estimated survival was 78%. Estimated 5-years primary patency for groups A, B, and C was 71%, 81%, and 69%, respectively (<italic>P</italic> = 0.19). Estimated 5-years secondary patency for groups A, B, and C was 88%, 85%, and 84% (<italic>P</italic> = 0.85). Estimated 5-years freedom from reintervention for groups A, B, and C was 62%,<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Abstract</title> <p>To compare outcomes of popliteal artery aneurysm (PAA) repair by endovascular treatment, great saphenous vein (GSV) bypass, and prosthetic bypass.</p> <p>Single center retrospective analysis of patients presenting PAA from 2000 to 2013. Patients were divided into endovascular treatment (group A); GSV bypass (group B); and prosthetic graft bypass (group C). Outcomes were technical success, perioperative mortality, and morbidity. Survival, primary and secondary patency, and freedom from reintervention rate were estimated. Differences in ankle-brachial index (ABI), in-hospital length of stay (InH-Los), red blood cell (RBC) transfusion, and limb loss were reported. Mean follow-up was 49 (median: 35; 1–145; SD 42) months.</p> <p>Sixty-seven patients were included; 25 in group A, 28 in group B, and 14 in group C. PAA was symptomatic in 23 (34%) cases. Technical success was 100%. No perioperative death occurred. Three (4.5%) perioperative complications were reported with no significant difference between groups (<italic>P</italic> = 0.866). Five-years estimated survival was 78%. Estimated 5-years primary patency for groups A, B, and C was 71%, 81%, and 69%, respectively (<italic>P</italic> = 0.19). Estimated 5-years secondary patency for groups A, B, and C was 88%, 85%, and 84% (<italic>P</italic> = 0.85). Estimated 5-years freedom from reintervention for groups A, B, and C was 62%, 84%, and 70%, respectively (<italic>P</italic> = 0.16). A significant difference between preoperative ABI versus postoperative ABI was observed (<italic>P</italic> = 0.001). InH-LoS was significantly shorter in group A (<italic>P</italic> &lt; 0.001). RBC transfusions were required significantly less in group A when compared to group C (<italic>P</italic> = 0.045). Overall limb salvage was achieved in all but 1 patient.</p> <p>PAA repair has good early and long-term outcomes with different treatment options. Endovascular treatment was not inferior to surgical repair with a reduced InH-LoS and RBC transfusion. It can be successfully employed even in nonelective setting. A randomized controlled trial with long-term follow-up and appropriate patient inclusion criteria is necessary to compare these 3 treatment options.</p> </sec> </abstract> … (more)
- Is Part Of:
- Medicine. Volume 94:Issue 30(2015)
- Journal:
- Medicine
- Issue:
- Volume 94:Issue 30(2015)
- Issue Display:
- Volume 94, Issue 30 (2015)
- Year:
- 2015
- Volume:
- 94
- Issue:
- 30
- Issue Sort Value:
- 2015-0094-0030-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-07
- Subjects:
- Medicine -- Periodicals
Medicine -- Periodicals
Médecine -- Périodiques
Geneeskunde
Medicine
Periodicals
Periodicals
610.5 - Journal URLs:
- http://journals.lww.com/md-journal/pages/default.aspx ↗
http://gateway.ovid.com/ovidweb.cgi?T=JS&PAGE=toc&D=ovft&MODE=ovid&NEWS=N&AN=00002060-000000000-00000 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MD.0000000000001130 ↗
- Languages:
- English
- ISSNs:
- 0025-7974
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5534.000000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3170.xml